Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (HKG:6990)
Hong Kong · Delayed Price · Currency is HKD 462.00
+15.00 (3.36%)
May 29, 2026, 4:08 PM HKT
HKG:6990 Market Cap
HKG:6990 has a market cap or net worth of 107.73 billion as of May 29, 2026. Its market cap has increased by 47.18% in one year.
Market Cap
107.73B
Enterprise Value
102.85B
Revenue
2.29B
Ranking
n/a
PE Ratio
n/a
Stock Price
462.00
Market Cap Chart
Since July 11, 2023, HKG:6990's market cap has increased from 13.49B to 107.73B, an increase of 698.65%. That is a compound annual growth rate of 105.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 107.73B | 17.80% |
| Dec 31, 2025 | 91.46B | 146.43% |
| Dec 31, 2024 | 37.11B | 64.54% |
| Dec 29, 2023 | 22.56B | 67.21% |
| Jul 11, 2023 | 13.49B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 261.30B |
| WuXi Biologics | 134.08B |
| Innovent Biologics | 130.11B |
| Akeso | 106.12B |
| Sino Biopharmaceutical | 85.77B |
| RemeGen | 60.91B |
| Biocytogen Pharmaceuticals (Beijing) | 49.27B |
| 3SBio | 43.14B |